Tag Archives: biotech

Free EPO webcast: Biotechnology patents

Visit the EPO site “VCL – Biotechnology patents” for information about a free webcast coming up in October.  They are now taking registrations.

The summary included the following extract:

“Patents for life is an emotive topic – the subject of fierce debate and ethical concerns for over a decade. This area of patent law, more than any other, is subject to caveats, provisos and prohibitions regarding what can be patented. Technologies using proteins, enzymes, genes and stem cells stand to benefit mankind with new medical treatments, but the public, law-makers and patent offices nevertheless insist on strict limits to patent exclusivity.”

This one hour webcast is a taster for longer sit-in workshops taking place in November.

“Can Biotech Food Cure World Hunger?”

Victoria Henson-Apollonio, the CAS-IP manager, sent me this link:

http://roomfordebate.blogs.nytimes.com/2009/10/26/can-biotech-food-cure-world-hunger/

For those of us who are involved in food security, this is extremely stimulating because a number of experts present their viewpoints on the question.  Here is a sampling:

Paul Collier: The debate over genetically modified crops and food has been contaminated by political and aesthetic prejudices: hostility to U.S. corporations, fear of big science and romanticism about local, organic production.

Vandana Shiva: Food security over the next two decades will have to be built on ecological security and climate resilience. We need the real green revolution, not a second “Green Revolution” based on genetic engineering.

Raj Patel: The U.S. leads the world in genetically modified agricultural technology, yet one in eight Americans is hungry. Last year, with bumper harvests, more than a billion people ate less than 1,900 calories per day. The cause of hunger today isn’t a shortage of food — it’s poverty.

Whatever we think about biotechnology, this NYTimes blog makes an even-handed effort to present a number of expert opinions in some depth.  One thing is for sure – everyone has strong views on the subject!

The CGIAR provides a perspective within the context of the Alliance mission at: http://www.cgiar.org/impact/agribiotech.html

This overview observes that:

As transgenics could offer important options for meeting food demand and environmental challenges, many scientists dedicated to reducing hunger and creating wealth among poor farmers consider such new technologies to be one part of the tool box of possible solutions.

Post written by Peter Bloch, consultant to CAS-IP

Further to this post I was sent a link (thanks Keith!) “Food: is Monsanto the answer or the problem?” where Reuters have mapped out where GM crops are cultivated and made comparisons between GM and non-GM.  It provides useful snapshot of information for the context of this post.

Biotech-GMO-crops & regulatory hurdles

http://www.patentdocs.org/2009/06/biotechpharma-docket.html
The second half of the post linked to above from Patent Docs.org deals with the refusal of the U.S Court of Appeals to lift an injunction preventing Monsanto selling its patented Roundup Ready alfalfa seed.
Victoria Henson-Apollonio made the following comment in relation to this news item:

“Here’s an example of regulatory hurdles and the complexity that companies face with biotech-GMO-crops.  Nothing to do with IP really.  Sometimes it seems there can be confusion over the range of issues associated with GMOs.  Patents are only a piece of the legal landscape and “FTO”.”